Skip to main content
OpenTrials

Clinical trial condition

Eye Diseases, Hereditary

Explore clinical trials studying Eye Diseases, Hereditary. Study availability and eligibility vary by location and protocol.

836 public trials 191 recruiting studies
Refine in advanced search Browse all conditions

Eye Diseases, Hereditary trial results

Completed

A Study Evaluating the Safety and Efficacy of ENV-101 (Taladegib) in Patients With Advanced Solid Tumors Harboring PTCH1 Loss of Function Mutations

NCT05199584

Conditions
Adenoma, Adenoma, Islet Cell, Brain Diseases, +52 more
Locations
  • Research Site Los Angeles, California, United States
  • Research Site Santa Rosa, California, United States
  • Research Site Tampa, Florida, United States
  • Research Site Zion, Illinois, United States
View all 16 locations
View Trial Details
Completed

A Study to Investigate the Safety and Efficacy of K-321 Eye Drops After Simultaneous Cataract Surgery and Descemetorhexis in Participants With Fuchs Endothelial Corneal Dystrophy (FECD)

NCT05826353

Conditions
Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Corneal Diseases, Corneal Dystrophies, Hereditary, +5 more
Locations
  • Keck Hospital of USC Los Angeles, California, United States
  • Macy Eye Center Los Angeles, California, United States
  • Byers Eye Institute at Stanford Palo Alto, California, United States
  • Sacramento Eye Consultants Sacramento, California, United States
View all 43 locations
View Trial Details
Completed

TEPEZZA® (Teprotumumab-trbw) Post-Marketing Requirement Study

NCT05002998

Conditions
Autoimmune Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Endocrine System Diseases, +12 more
Locations
  • The Private Practice of Raymond Douglas, MD - Beverly Hills Beverly Hills, California, United States
  • USC Roski Eye Institute - Los Angeles Los Angeles, California, United States
  • Stanford University Palo Alto, California, United States
  • University of Colorado - Eye Center - PPDS Aurora, Colorado, United States
View all 28 locations
View Trial Details
Completed

AGN-151597 (Formerly RST-001) Phase I/II Trial for Advanced Retinitis Pigmentosa

NCT02556736

Conditions
Advanced Retinitis Pigmentosa, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Eye Diseases, +6 more
Locations
  • University of California San Francisco - Mission Bay /ID# 235717 San Francisco, California, United States
  • Cincinnati Eye Institute- Edgewood /ID# 236713 Edgewood, Kentucky, United States
  • Duke Eye Center /ID# 235715 Durham, North Carolina, United States
  • Retina Foundation of the Southwest /ID# 235199 Dallas, Texas, United States
View Trial Details

Related conditions